Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1956 May;35(5):533–536. doi: 10.1172/JCI103306

THE ACTION OF HEPARIN IN THE PREVENTION OF PROTHROMBIN CONVERSION

A S Douglas 1
PMCID: PMC438841  PMID: 13319488

Full text

PDF
533

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALEXANDER B., GOLDSTEIN R., LANDWEHR G. The labile factor of prothrombin conversion: its consumption under normal and pathological conditions affecting blood coagulation. J Clin Invest. 1951 Mar;30(3):252–262. doi: 10.1172/JCI102439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BIGGS R. Assessment of clotting efficiency. Br Med Bull. 1955;11(1):5–10. doi: 10.1093/oxfordjournals.bmb.a069445. [DOI] [PubMed] [Google Scholar]
  3. BIGGS R., DOUGLAS A. S., MACFARLANE R. G. The action of thromboplastic substances. J Physiol. 1953 Dec 29;122(3):554–569. doi: 10.1113/jphysiol.1953.sp005020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BIGGS R., DOUGLAS A. S., MACFARLANE R. G. The formation of thromboplastin in human blood. J Physiol. 1953 Jan;119(1):89–101. doi: 10.1113/jphysiol.1953.sp004830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. BIGGS R., DOUGLAS A. S. The thromboplastin generation test. J Clin Pathol. 1953 Feb;6(1):23–29. doi: 10.1136/jcp.6.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. BROWN A., DOUGLAS A. S. Anticoagulants and anticoagulant therapy; a review. Glasgow Med J. 1952 Jun;33(6):225–254. [PMC free article] [PubMed] [Google Scholar]
  7. DOUGLAS A. S., BIGGS R. The consumption of some components involved in physiological blood coagulation. Glasgow Med J. 1953 Aug;34(8):329–342. [PMC free article] [PubMed] [Google Scholar]
  8. MACMILLAN R. L., BROWN K. W. Heparin and thromboplastin. J Lab Clin Med. 1954 Sep;44(3):378–386. [PubMed] [Google Scholar]
  9. McCLAUGHRY R. I., SEEGERS W. H. Prothrombin, thromboplastin, Ac-globulin and platelet accelerator: quantitative interrelationships. Blood. 1950 Apr;5(4):303–312. [PubMed] [Google Scholar]
  10. RATNOFF O. D., COLOPY J. E. A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. J Clin Invest. 1955 Apr;34(4):602–613. doi: 10.1172/JCI103109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. ROSENTHAL R. L., DRESKIN O. H., ROSENTHAL N. Plasma thromboplastin antecedent (PTA) deficiency; clinical, coagulation, therapeutic and hereditary aspects of a new hemophilia-like disease. Blood. 1955 Feb;10(2):120–131. [PubMed] [Google Scholar]
  12. SPAET T. H., AGGELER P. M., KINSELL B. G. A possible fourth plasma thromboplastin component. J Clin Invest. 1954 Aug;33(8):1095–1102. doi: 10.1172/JCI102982. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES